Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
✍ Scribed by G. BIOQUE; J. B. A. CRUSIUS; I. KOUTROUBAKIS; G. BOUMA; P. J. KOSTENSE; S. G. M. MEUWISSEN; A.S. PEÑA
- Book ID
- 110090333
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 456 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0009-9104
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Proinflammatory cytokines, including interleukin (IL)-1, are known to modulate effects of neurotoxic neurotransmitters discharged during excitation or inflammation in the central nervous system (CNS). They also regulate development of glial scars at sites of CNS injury. To elucidate a genetic predi
## Abstract The purpose of this study was to evaluate whether IL‐1 β (IL‐1β promoter and IL‐1β exon 5), IL‐1 receptor antagonist (IL‐1 __Ra__), and IL‐4 (IL‐4 promoter and IL‐4 intron 3) gene polymorphisms act as markers of susceptibility to Kawasaki disease (KD), or of the severity of the disease.
## Abstract ## BACKGROUND The principal components of the interleukin‐1 (IL‐1) family are two secreted factors (IL‐1α and IL‐1β), two transmembrane receptors (IL‐1RI [biologically active] and IL‐1RII [inert receptor]), and a natural antagonist receptor of IL‐1 function (IL‐1Ra). Changes in the exp
## Abstract Inflammation and genetics may play a role in the pathogenesis of febrile seizures (FSs). We aimed to test whether interleukin‐1β (IL‐1β), IL‐1 receptor antagonist (IL‐1 Ra), IL‐6 promoter, IL‐8, IL‐10, or tumor necrosis factor (TNF) gene polymorphisms could be used as markers of suscept